This inventor holds 6 USPTO granted patents. Top assignees: Glaxo Group Limited, Merck Sharp + Dohme Corp.. Active years: 1986-2002.
Location History:
- Little Hadham, GB (1990)
- Saffron Walden, GB (1993)
- Ware, GB (1986 - 2002)
Company Filing History:
Years Active: 1986-2002
Title: The Innovative Contributions of Anthony John Phillips
Introduction
Anthony John Phillips is a notable inventor based in Ware, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of migraine. With a total of 6 patents to his name, Phillips has demonstrated a commitment to advancing medical science through his innovative ideas.
Latest Patents
One of his latest patents focuses on compositions for treating migraine. This pharmaceutical composition is designed for oral administration and includes a film-coated solid dosage form containing 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as the active ingredient. These film-coated solid dosage forms are particularly useful in treating conditions associated with cephalic pain, especially migraine.
Career Highlights
Throughout his career, Phillips has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Phillips has collaborated with several professionals in his field, including Ian Keith Winterborn and John M Padfield. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Anthony John Phillips is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly improve the treatment of migraine. His innovative spirit and dedication to medical science continue to inspire advancements in the field.